Novavax Inc (NVAX) Highlights Financial Concerns Amid Ongoing Strategic Reshaping
Shift in Strategy
The biotechnology firm has been undergoing a shift in strategy to focus more on its pipeline of vaccines, moving away from certain non-core assets.
Shift in Strategy
The biotechnology firm has been undergoing a shift in strategy to focus more on its pipeline of vaccines, moving away from certain non-core assets.